Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial
地诺单抗作为HER2阴性早期乳腺癌的免疫调节剂：D-BIOMARK临床试验的窗口期结果
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-01996-w
Vethencourt, Andrea; Trinidad, Eva M; Dorca, Eduard; Petit, Anna; Soler-Monsó, M Teresa; Ciscar, Marina; Barranco, Alexandra; Pérez-Chacón, Gema; Jimenez, María; Rodríguez, Mario; Gomez-Aleza, Clara; Purqueras, Elvira; Hernández-Jiménez, Enrique; Urruticoechea, Ander; Morilla, Idoia; Subirana, Isaac; García-Tejedor, Amparo; Gil-Gil, Miguel; Pernas, Sonia; Falo, Catalina; Gonzalez-Suarez, Eva
